Steel Therapeutics
Iowa, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into Steel Therapeutics
141 people in our graph share verified history with the Steel Therapeutics team — schools, employers, funds. One of them is your warm intro.
Maia Hightowerunlockedknows Matt Stahl · together at University of Iowa Health Care (overlapped)
×10knows the team · via University of Iowa
knows the team · via DocStation
Steel Therapeutics is a pharmaceutical company that develops a pipeline of drug candidates and manages the associated regulatory, clinical, and product delivery work. It draws on pharmacy compounding and clinical trial expertise to bring medications to market.
Founders & leadership
Steel Therapeutics was founded in 2020 by Matt Stahl, Matt Stahl, PharmD, Robbie Schwenker, PharmD, and Allen Phillips MBA, CMA.
MS
Matt StahlinCEO & FounderMatt Stahl earned a Doctor of Pharmacy from the University of Iowa College of Pharmacy and is CEO and founder of Steel Therapeutics, a pharmaceutical company developing drug candidates for clinical trials and market delivery.
MS
Matt Stahl, PharmDCEO & Founder
RS
Robbie Schwenker, PharmDCSO & Founder
AP
Allen Phillips MBA, CMACFO & Founder
BC
Ben ClarkinPresident & COO
Board
AP
Allen PhillipsCFO & Founder
SC
Sunny ChapelBoard director
DS
Dennis SparksBoard director
RS
Robbie SchwenkerCSO & Founder
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.1M disclosed across 4 rounds · 2021–2024
▶$2MraisedDec 2024 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedDec 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Allen PhillipsDirector
- Sunny ChapelDirector
- Benjamin ClarkExecutive Officer, Promoter
- Dennis SparksDirector
- Robbie SchwenkerDirector
- Matthew StahlExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $100K
- Proceeds to insiders
- $250K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3MraisedJun 2023 · 1 investors · Other Health CareRule 506(b)
▶$3MraisedJun 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis SparksDirector
- Benjamin ClarkExecutive Officer, Promoter
- Matthew StahlExecutive Officer, Director, Promoter
- Robbie SchwenkerDirector
- Allen PhillipsDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $10K
- Proceeds to insiders
- $600K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.8MraisedApr 2022 · 8 investors · Other Health CareRule 506(b)
▶$1.8MraisedApr 2022 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Allen PhillipsDirector
- Benjamin ClarkExecutive Officer, Promoter
- Robbie SchwenkerDirector
- Matthew StahlExecutive Officer, Director, Promoter
- Dennis SparksDirector
- Offering amount
- $2M
- Amount sold
- $1.8M
- Minimum investment
- $10K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$378KraisedJun 2021 · 40 investors · Other Health Care
▶$378KraisedJun 2021 · 40 investors · Other Health Care
Officers, directors & promoters on the filing
- Robbie SchwenkerExecutive Officer, Director
- Allen PhillipsExecutive Officer, Director
- Matthew StahlExecutive Officer, Director
- Offering amount
- $400K
- Amount sold
- $378K
- Minimum investment
- $1K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapApplied Therapeutics9 shared keywordsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.
Click Therapeutics7 shared keywordsClick Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy. It targets diseases through a platform-based approach applying neuroscience and neuromodulatory mechanisms for patients with unmet medical needs.
AltaThera Pharmaceuticals6 shared keywordsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
Ostealtx5 shared keywordsOsteal Therapeutics is a clinical-stage pharmaceutical company developing novel treatments for orthopedic infections, particularly periprosthetic joint infections. Its lead product, NEXCHANGE KIT, is a drug-device combination designed for localized antibiotic delivery to infected joint prostheses.
Companies competing with Steel Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Steel Therapeutics do?
- Steel Therapeutics is a pharmaceutical company that develops a pipeline of drug candidates and manages the associated regulatory, clinical, and product delivery work. It draws on pharmacy compounding and clinical trial expertise to bring medications to market.
- Who founded Steel Therapeutics?
- Steel Therapeutics was founded by Matt Stahl, Matt Stahl, PharmD, Robbie Schwenker, PharmD, Allen Phillips MBA, CMA in 2020.
- Who are Steel Therapeutics's investors?
- Steel Therapeutics's investors include ISA Ventures.
- How much funding has Steel Therapeutics raised?
- Steel Therapeutics has disclosed $7.1M raised across 4 rounds.
- Where is Steel Therapeutics headquartered?
- Steel Therapeutics is headquartered in Iowa, US.